"
Team:Ciencias-UNAM
From 2013.igem.org
Nataquinones (Talk | contribs) |
Nataquinones (Talk | contribs) |
||
| Line 447: | Line 447: | ||
<div id="u56" class="u56" > | <div id="u56" class="u56" > | ||
| - | <div id="u56_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:13px;font-weight:normal;font-style:normal;text-decoration:none;color:#666666;">We submitted several devices mainly to test and use the following parts: <b>Cathelicidin LL-37:</b> An antimicrobial peptide against bacterial infection | + | <div id="u56_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:13px;font-weight:normal;font-style:normal;text-decoration:none;color:#666666;">We submitted several devices mainly to test and use the following parts:<br><b>Cathelicidin LL-37:</b> An antimicrobial peptide against bacterial infection.<br> <b>MarA:</b> A peptide responsible for an efflux pump in <i>E. coli</i> that is related to its resistance to cathelicidin and similar peptides.</span></p></div> |
</div> | </div> | ||
Revision as of 22:58, 21 September 2013
HOME
PROJECT
HUMAN PRACTICES
TEAM
SAFETY
Overview
General Design
Wet Lab
Dry Lab
Conclusions
References
Bios
Sponsors
Overview
Journalism
Interviews
THE PROJECT
THE PEOPLE
PARTS
ACHIEVEMENTS
We designed a synthetic system in E. coli to express an antimicrobial peptide (Cathelicidin LL-37) in vivo only in the presence of a quorum sensing molecule (AI-2) and expel it with an efflux pump in order to act against targeted gastrointestinal pathogens. This is an effort to explore alternatives were some drug administration issues could be solved with Synthetic Biology.
We are the team from Facultad de Ciencias, UNAM in Mexico City. Our team brings together students and teachers from all over the country, with various backgrounds and interests.
We submitted several devices mainly to test and use the following parts:
Cathelicidin LL-37: An antimicrobial peptide against bacterial infection.
MarA: A peptide responsible for an efflux pump in E. coli that is related to its resistance to cathelicidin and similar peptides.
Praesent libero arcu, convallis et dapibus sit amet, aliquet nec nibh. Nulla eu aliquam orci. Phasellus vitae nunc ut urna tincidunt accumsan vel ac dui. Donec tempus quis quam vitae ultrices. Vestibulum congue nec odio eget dictum. Sed tincidunt velit enim. Fusce metus augue, lobortis eget viverra sit amet, fringilla.
Read the abstract
Meet the team
Read more...
Read more...
Gallery
